Abstract
Cystic fibrosis (CF) patients have endobronchial inflammation caused by infection with mucoid Pseudomonas aeruginosa. Since adenovirus vectors are being studied for gene therapy for CF, we sought to determine whether bronchopulmonary inflammation would influence adenovirus-mediated gene transfer. We hypothesized that bronchopulmonary inflammation in mice inoculated with mucoid P. aeruginosa would be associated with a decrease in the efficacy of adenovirus-mediated gene transfer. Agarose beads embedded with mucoid P. aeruginosa (6 x 104 c.f.u. per mouse) were inoculated transtracheally into C57BL/6 mice. Control mice received sterile agarose beads. Ten days after inoculation with agarose beads, recombinant adenovirus containing the β-galactosidase reporter gene, (Ad2/βGal-2) was administered intranasally (1.1 x 109 IU per mouse), and mice were killed 3 days later. The extent of inflammation, determined by neutrophil numbers in bronchoalveolar lavage fluid and by areal lung inflammation, was significantly greater in mice inoculated with P. aeruginosa-laden agarose beads and Ad2/βGal-2 compared with controls. Mice that had received Pseudomonas-laden agarose beads and Ad2/βGal-2 had significantly fewer (P < 0.015) airway epithelial cells transduced (4.1 ± 0.9%) compared with mice that received sterile agarose beads and Ad2/βGal-2 (9.4 ± 1.4%). These results indicate that the efficacy of adenovirus-mediated gene transfer is reduced in Pseudomonas-induced bronchopulmonary inflammation.
Original language | English |
---|---|
Pages (from-to) | 345-351 |
Number of pages | 7 |
Journal | Gene therapy |
Volume | 5 |
Issue number | 3 |
DOIs | |
State | Published - 1998 |
Keywords
- Adenovirus
- Cystic fibrosis
- Gene therapy
- Neutrophils
- Pseudomonas aeruginosa